Hongbin Deng

4.3k total citations
58 papers, 1.4k citations indexed

About

Hongbin Deng is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hongbin Deng has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Oncology and 14 papers in Immunology. Recurrent topics in Hongbin Deng's work include Berberine and alkaloids research (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and CAR-T cell therapy research (5 papers). Hongbin Deng is often cited by papers focused on Berberine and alkaloids research (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and CAR-T cell therapy research (5 papers). Hongbin Deng collaborates with scholars based in China, United States and Hong Kong. Hongbin Deng's co-authors include Danqing Song, Xiaojia Liu, Qingxuan Zeng, Genxiang Mao, Mingxiao Yin, Dian-Dong Li, Yanxiang Wang, Jingwen Dong, Tianyun Fan and Jian‐Dong Jiang and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Hongbin Deng

54 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongbin Deng China 22 675 329 311 250 178 58 1.4k
Dongmei Wang China 21 808 1.2× 296 0.9× 187 0.6× 266 1.1× 145 0.8× 63 1.7k
Zhou‐Yan Bian China 31 1.1k 1.7× 259 0.8× 163 0.5× 270 1.1× 189 1.1× 63 2.2k
Do Young Lim United States 25 1.0k 1.5× 334 1.0× 231 0.7× 287 1.1× 111 0.6× 44 1.9k
Jianchang Qian China 23 719 1.1× 190 0.6× 137 0.4× 177 0.7× 119 0.7× 62 1.5k
Weixing Shen China 24 865 1.3× 203 0.6× 176 0.6× 191 0.8× 153 0.9× 94 1.7k
Hongwei He China 27 888 1.3× 397 1.2× 177 0.6× 130 0.5× 477 2.7× 97 1.9k
Yue Jin China 25 881 1.3× 132 0.4× 123 0.4× 231 0.9× 229 1.3× 44 1.8k
Zebo Jiang China 23 771 1.1× 341 1.0× 153 0.5× 236 0.9× 112 0.6× 52 1.5k
Yueh-Min Lin Taiwan 25 649 1.0× 290 0.9× 132 0.4× 125 0.5× 144 0.8× 62 1.4k
Yun‐Ching Chang Taiwan 28 897 1.3× 347 1.1× 99 0.3× 204 0.8× 138 0.8× 60 2.0k

Countries citing papers authored by Hongbin Deng

Since Specialization
Citations

This map shows the geographic impact of Hongbin Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbin Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbin Deng more than expected).

Fields of papers citing papers by Hongbin Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongbin Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbin Deng. The network helps show where Hongbin Deng may publish in the future.

Co-authorship network of co-authors of Hongbin Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Hongbin Deng. A scholar is included among the top collaborators of Hongbin Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongbin Deng. Hongbin Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Dian, Fei Xie, Jianfeng Wang, et al.. (2025). Polyvalent folate receptor-targeting chimeras for degradation of membrane proteins. Nature Chemical Biology. 21(11). 1731–1741. 5 indexed citations
2.
Long, Yu, Fei Xie, Lianqi Liu, et al.. (2025). Novel Quaternary Ammonium Salt‐Linked STING Agonist Antibody‐Drug Conjugate: Synergistic Activation of Tumor Immunity with Mitigated Off‐Target Toxicity. Advanced Science. 12(31). e02270–e02270. 2 indexed citations
3.
Xiao, Dian, Lianqi Liu, Fei Xie, et al.. (2024). Azobenzene‐Based Linker Strategy for Selective Activation of Antibody–Drug Conjugates. Angewandte Chemie. 136(16). 3 indexed citations
4.
Sun, Chengliang, Yao Cheng, Jingwen Dong, et al.. (2024). Novel PD-L1/VISTA Dual Inhibitor as Potential Immunotherapy Agents. Journal of Medicinal Chemistry. 68(1). 156–173. 3 indexed citations
5.
Xiao, Dian, Lianqi Liu, Fei Xie, et al.. (2024). Azobenzene‐Based Linker Strategy for Selective Activation of Antibody–Drug Conjugates. Angewandte Chemie International Edition. 63(16). e202310318–e202310318. 21 indexed citations
6.
Wang, Kun, Yinghong Li, Rong‐Mei Gao, et al.. (2023). Chemical construction and anti-HCoV-OC43 evaluation of novel 10,12-disubstituted aloperine derivatives as dual cofactor inhibitors of TMPRSS2 and SR-B1. Chinese Chemical Letters. 35(5). 108792–108792. 1 indexed citations
7.
Yin, Mingxiao, Jingwen Dong, Cuicui Sun, et al.. (2023). Raddeanin A Enhances Mitochondrial DNA‐cGAS/STING Axis‐Mediated Antitumor Immunity by Targeting Transactive Responsive DNA‐Binding Protein 43. Advanced Science. 10(13). e2206737–e2206737. 33 indexed citations
8.
Zhang, Na, Tianyun Fan, Liping Zhao, et al.. (2022). Discovery and development of palmatine analogues as anti-NASH agents by activating farnesoid X receptor (FXR). European Journal of Medicinal Chemistry. 245(Pt 1). 114886–114886. 10 indexed citations
9.
Sun, Chengliang, Mingxiao Yin, Yao Cheng, et al.. (2022). Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune Microenvironment. Journal of Medicinal Chemistry. 66(3). 2064–2083. 33 indexed citations
10.
Sun, Chengliang, Yao Cheng, Xiaojia Liu, et al.. (2022). Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents. Acta Pharmaceutica Sinica B. 12(12). 4446–4457. 25 indexed citations
11.
Wei, Wei, Qingxuan Zeng, Yan Wang, et al.. (2022). Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects. Acta Pharmaceutica Sinica B. 13(5). 2138–2151. 55 indexed citations
12.
Li, Minmin, et al.. (2021). Reirradiation of Whole Brain for Recurrent Brain Metastases: A Case Report of Lung Cancer With 12-Year Survival. Frontiers in Oncology. 11. 780581–780581. 3 indexed citations
13.
Deng, Hongbin, et al.. (2021). Serum magnesium level as a predictor of acute kidney injury in patients with acute pancreatitis. World Journal of Clinical Cases. 9(35). 10899–10908. 4 indexed citations
14.
Zeng, Qingxuan, Kun Wang, Xin Zhang, et al.. (2021). Structure–activity relationship and biological evaluation of 12 N-substituted aloperine derivatives as PD-L1 down-regulatory agents through proteasome pathway. Bioorganic Chemistry. 117. 105432–105432. 4 indexed citations
15.
Zeng, Qingxuan, Hongbin Deng, Yinghong Li, et al.. (2020). Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3 Interaction and Exert Anti-inflammatory Activity. Journal of Medicinal Chemistry. 64(1). 768–781. 76 indexed citations
16.
Zhang, Xin, Qiang Liu, Qianqian Li, et al.. (2018). Synthesis and biological evaluation of novel tricyclic matrinic derivatives as potential anti-filovirus agents. Acta Pharmaceutica Sinica B. 8(4). 629–638. 8 indexed citations
17.
Zhang, Xin, Qiang Liu, Na Zhang, et al.. (2018). Discovery and evolution of aloperine derivatives as novel anti-filovirus agents through targeting entry stage. European Journal of Medicinal Chemistry. 149. 45–55. 32 indexed citations
18.
Wang, Yanxiang, Qingxuan Zeng, Tianyun Fan, et al.. (2017). Synthesis and biological evaluation of new berberine derivatives as cancer immunotherapy agents through targeting IDO1. European Journal of Medicinal Chemistry. 143. 1858–1868. 66 indexed citations
19.
Deng, Hongbin, Na Zhang, Yan Wang, et al.. (2012). S632A3, a new glutarimide antibiotic, suppresses lipopolysaccharide-induced pro-inflammatory responses via inhibiting the activation of glycogen synthase kinase 3β. Experimental Cell Research. 318(20). 2592–2603. 18 indexed citations
20.
Deng, Hongbin. (2005). The Study of p53、VEGF、MVD Expressions and Their Correlations in Non-small Cell Lung Cancer. Zhongliu fangzhi yanjiu. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dongmei Wang Breakdown of academic impact, for papers by Zhou‐Yan Bian Breakdown of academic impact, for papers by Do Young Lim Breakdown of academic impact, for papers by Jianchang Qian Breakdown of academic impact, for papers by Weixing Shen Breakdown of academic impact, for papers by Hongwei He Breakdown of academic impact, for papers by Yue Jin Breakdown of academic impact, for papers by Zebo Jiang Breakdown of academic impact, for papers by Yueh-Min Lin Breakdown of academic impact, for papers by Yun‐Ching Chang
Rankless by CCL
2026